The SGK1 Gene (Serum/Glucocorticoid-Regulated Kinase 1) is a serine/threonine protein kinase that plays critical roles in cellular stress response, neuronal survival, and glucocorticoid-mediated signaling. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
Sgk1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
SGK1 (Serum/Glucocorticoid-Regulated Kinase 1) is a serine/threonine protein kinase encoded by the SGK1 gene located on chromosome 6q23 (6q23.2). The gene spans approximately 25 kb and consists of 13 exons[2]. [3]
The SGK1 gene encodes multiple splice variants: [4]
The protein contains an N-terminal catalytic domain, a hydrophobic motif, and a C-terminal regulatory domain[1:1]. [5]
SGK1 is a member of the AGC kinase family (PKA/PKB/PKC-related) with diverse cellular functions: [6]
SGK1 activates the epithelial sodium channel (ENaC), TRPV5, and other ion channels through phosphorylation[3:1]. This regulation affects neuronal excitability and calcium homeostasis. [7]
SGK1 promotes cell survival through Akt-independent pathways by phosphorylating pro-apoptotic proteins like BAD and FOXO transcription factors[4:1]. [8]
SGK1 mediates many effects of glucocorticoids and is rapidly upregulated by glucocorticoid receptor activation[5:1]. This connection is particularly relevant to stress-related neurodegeneration.
SGK1 is activated by various cellular stresses:
SGK1 promotes neuronal survival through multiple mechanisms:
SGK1 is widely expressed throughout the brain and peripheral tissues:
| Brain Region | Expression Level |
|---|---|
| Hippocampus | High |
| Cerebral Cortex | High |
| Substantia Nigra | Moderate |
| Cerebellum | Moderate |
| Hypothalamus | Moderate |
Peripheral expression includes kidney, heart, liver, and adipose tissue[6:1].
SGK1 plays complex roles in AD pathophysiology:
In PD, SGK1 has been studied for its neuroprotective potential:
SGK1 shows neuroprotective effects in ischemic conditions:
Emerging evidence suggests SGK1 involvement in ALS:
SGK1 represents a promising therapeutic target:
The study of Sgk1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nishimoto T, et al. (2015) SGK1 is a novel therapeutic target for Parkinson's disease. Mol Brain. 2015. ↩︎ ↩︎
Shoemaker LB, et al. (2006) Serum- and glucocorticoid-regulated kinase 1 in Alzheimer's disease. J Neurochem. 2006. ↩︎ ↩︎
Tai DJ, et al. (2009) SGK1 is a key mediator of glucocorticoid action in the brain. Mol Endocrinol. 2009. ↩︎ ↩︎
Brunet A, et al. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 2001. ↩︎ ↩︎
Webster MK, et al. (1993) Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol. 1993. ↩︎ ↩︎
Firestone GL, et al. (2003) The role of SGK1 in hormone-regulated tumorigenesis. Mol Cell Endocrinol. 2003. ↩︎ ↩︎
Liu L, et al. (2018) SGK1 regulates tau phosphorylation in Alzheimer's disease. J Alzheimers Dis. 2018. ↩︎ ↩︎
Jia Y, et al. (2020) SGK1 protects dopaminergic neurons against oxidative stress via Nrf2 activation. Redox Biol. 2020. ↩︎ ↩︎